Abstract. Hepatocellular carcinoma (Hcc) is one of the most common types of cancer worldwide. The initial hepatocellular alterations that precede the appearence of Hcc include chronic viral hepatitis/cirrhosis, foci of phenotypically altered hepatocytes and, subsequently, dysplastic hepatocytes that form foci and nodules. These changes cause a discrepancy in the microenvironment of liver cells, which may result in changes in the protein expression profile of the cells. The aim of the present study was to investigate differences between the protein expression profiles at various stages of liver disease in order to better understand the mechanisms of Hcc and to identify potential biomarkers for its early diagnosis. The proteins of specific cells were obtained from Hcc tissue sections and pre-cancerous lesions using a manual microdissection technique, and were investigated by a two dimensional gel electrophoresis (2-de) Maldi-ToF MS proteomics approach. Select identified proteins were reconfirmed by immunohistochemistry. A total of 95 differentially expressed proteins, with an over 2-fold disparity in expression levels between cells of varying morphology during the stages of hepatocarcinogenesis, were detected by 2-de. among these 95 proteins, 80 were determined to be involved in numerous cell functions, including cell growth and proliferation, protein synthesis and metabolism, apoptosis and signal transduction. These identified proteins, which include stratifin (14-3-3), transgelin 2, heat-shock protein (HSP)70, HSP27, manganese superoxide dismutase, prohibitin, dJ1, α-enolase, peroxiredoxin 6, aldo-keto reductase family member B10, phosphoglycerate kinase 1, α-1-antitrypsin and nm23-H1, may play a role in the development of Hcc. Protein expression profiles differed markedly between the HCC tissue samples and pre-cancerous lesions, suggesting that alterations in protein expression occurred frequently during the process of hepatocarcinogenesis. analysis of the differential expression of proteins related to the development of Hcc may help elucidate the molecular mechanisms of the disease. These proteins may also serve as candidate biomarkers for early Hcc diagnosis.
Introduction
Hepatocellular carcinoma (Hcc) is one of the world's most common malignancies. The majority of Hcc cases are associated with chronic hepatitis or cirrhosis. Pathological changes in Hcc are involved in liver cell degeneration and necrosis, inflammatory cell infiltration, hepatocyte regeneration and fibrous tissue proliferation. During the development of Hcc, the liver undergoes a series of morphological changes, including chronic viral hepatitis/cirrhosis, foci of phenotypically altered hepatocytes and atypical hyperplasia (1) (2) (3) (4) . These changes result in an altered microenvironment, in which the intracellular protein expression pattern is changed as well.
The proteomics approach allows for the analysis of changes in the protein expression profile of cells during disease progression. By comprehensively analyzing changes in protein expression patterns over the course of disease progression, valuable information may be generated for the early diagnosis and treatment of liver cancer. using a combination of proteomics techniques, classic morphological pathology and microdissection, we analyzed the protein expression profile of hepatocarcinogenesis at various stages of liver disease (including chronic viral hepatitis, cirrhosis, foci of altered hepatocytes and atypical hyperplasia) and in different histological types of liver cancer. The aim of this study was to elucidate the molecular mechanisms of liver cancer, and to identify valuable candidate biomarkers for the early diagnosis of the disease.
Materials and methods
Reagents and instruments. immobilized pH gradient dry strips (iPG strip, pH 3-10nl, 13 cm), iPG buffer (pH 3-10nl), covering liquid, a silver staining kit, iPGphor isoelectric focusing instrument, Se600 vertical electrophoresis tank, electrophoresis device and image Master 5.0 image analysis software were purchased from amersham Biosciences inc. (Sweden). centrifugal dryers and an aBi Voyager de Maldi-ToF mass spectrometer were from applied Biosystems (uSa). dithiothreitol (dTT), iodoacetamide (iaa), sequencing grade TPcK Trypsin (TPcK-trypsin), trifluoroacetic acid (TFa), matrix α-cyano-4-hydroxy-cinnamic acid (cHca), TBP, oBG and MeGa-10 were purchased from Sigma. Silver nitrate, acrylamide, methylene bis-acrylamide, urea, thiourea, glycine, Tris, cHaPS and SdS were from Promega (uSa). all solutions were prepared with MilliQ water.
Microdissection and sample preparation. Fresh specimens from Hcc surgical resections were collected and the nonnecrotic area was pathologically confirmed. Frozen sections (5 µm) of Hcc and adjacent cirrhosis samples were processed separately. The cancer cells and the altered hepatocytes were identified by routine H&E staining observed under an optical microscope, carefully marked with the syringe needle at a low magnification, and excised. The remaining 10 to 15-µm thick continuous frozen sections with no staining were neatly stacked under the slice of H&E stained tissue (ice operation) using a scalpel to obtain the corresponding parts of the tissue, and then collected into a 1.5-ml eppendorff tube with lysis buffer. The tissue cells were lyzed in a cocktail of 9 mol/l urea, 40 g/l cHaPS, 40 mmol/l Tris and 40 mmol/l dTT and centrifuged at 40,000 x g for 1 h at 4˚C. Protein concentrations were determined by the Bradford method. all samples were stored in aliquots at -80˚C before analysis.
Two-dimensional electrophoresis. Two-dimensional electrophoresis (2-de) was manually performed according to the manufacturer's instructions with minor modifications. Firstdimension isoelectric focusing (ieF) is an electrophoretic method that separates proteins according to their isoelectric points (pi). ieF was carried out on an iPGphor system (amersham Biosciences inc.) using 13-cm strips (pH 3-10, non-linear) and 80 µg of protein in a 250 µl sample solution. rehydration and isoelectric focusing were automatically performed at 20˚C and 60 µA per strip as follows: 30 V, 6 h; 60 V, 6 h; 200 V, 2 h; 500 V, 2 h; 1,000 V, 1 h; 8,000 V, 3 h. after ieF, the focused strips were equilibrated in balanced solution Ⅰ (6 mol/l urea, 30% glycerol, 2% SDS and 1% DTT) and balanced solution Ⅱ (6 mol/l urea, 30% glycerol, 2% SDS and 2.5% IAA) for 15 min, respectively, with gentle agitation. Second dimensional separation was performed on 12.5% SdS-PaGe at a 30-ma constant current per gel using Hoefer Se600 vertical gel electrophoresis chambers. The proteins were separated according to molecular weight.
Silver nitrate staining. 2-de gels were stained with silver nitrate according to the kit instructions. The basic processes were as follows: the gels were fixed in 40% methanol and 10% acetic acid for 1 h or overnight, sensitized in 30% methanol, 0.2% Na 2 S 2 o 3 and 6.8% anhydrous sodium acetate for 30 min, and stained with 0.25% silver nitrate for 20 min. After that, the gels were developed in 2.5% sodium carbonate and 0.0074% formaldehyde for 5-10 min to reveal visible clear spots, then 1.46% EDTA Na 2 •H 2 o was added in a timely fashion to terminate the reaction. The above steps were carried out at room temperature on a shaker. The stained gels were stored in 1% (v/v) acetic acid at 4˚C.
Gel image analysis.
The stained gels were captured by transmission scanning and were analyzed with image Master 5.0. Through spot detection, comparative and quantitative analysis, protein spots with a staining intensity increased by more than 2-fold were identified and determined to be differentially expressed. The selected protein spots were manually excised from the gels and stored at -80˚C until analysis.
In-gel digestion. in-gel digestion of proteins was carried out according to Zhou's method (5) with minor modifications. Briefly, the differentially expressed protein spots were de-stained with 100 mmol/l sodium thiosulfate and 30 mmol/l potassium ferricyanide (1:1), reduced with 10 mmol/l dTT, 25 mmol/l ammonium bicarbonate (nH 4 Hco 3 ) for 1 h at 56˚C, then incubated with 25 mmol/l NH 4 Hco 3 and 55 mmol/l iodine acetamide solution in the dark for 45 min. after drying, the protein spots were incubated with TPcK-trypsin enzyme (0.05 µg/µl) overnight at 37˚C. Tryptic digests were extracted with 50% acetonitrile (CAN) + 0.2% TFA by ultrasonic extraction for 15 min. The polypeptide extracts were dried in a vacuum concentrator at room temperature.
MALDI-TOF MS analysis of polypeptide samples.
Mass spectrometry analysis was performed using the Voyager-de Maldi-ToF mass spectrometer, operated in the delayed extraction and linear mode. The peptide samples were combined with saturated cHca matrix. The Maldi spectra averaged over 100 laser shots. all mass spectra were calibrated externally using a standard peptide mixture (angiotensin Ⅰ, neurotensin, acTH1-17 and acTH18-39). internal calibration was performed using the auto-digestion peaks of trypsin.
Database searching and identification of proteins. Mascot (http://www.matrixscience.com) and ProFound (http://prowl. rockfeller.edu) software was used to search for the peptide mass fingerprints obtained by the MALDI-TOF MS in the ncBinr, MSdB or SWiSS-ProT databases. The parameters of the search were as follows: the mass of peptide fragments ranged from 800 to 5,000 da, one missed cleavage site was allowed; the peptide molecular weight maximum allowable error was ±1.0 da, and restriction was placed on the species of Homo sapiens. The modifications allowed for the carboxyamidomethylation of cysteine and oxidation of methionine (carbamidomethyl-cys).
Immunohistochemistry. Samples from 27 cases of liver cancer (22 males and 5 females; 26-85 years of age, mean 52.5) and 10 cases of liver cirrhosis (6 males and 4 females; 33-68 years of age, mean 46.7) were fixed in 10% neutral formalin, paraffin-embedded, cut into 5-µm serial sections and placed on APES-coated glass slides. The slides were incubated at 65˚C for 24 h, then stored at -70˚C until use. Immunohistochemical staining was performed with mouse anti-human cathepsin d (cath d) and heat-shock protein 70 (HSP70) monoclonal antibodies (chemicon inc.). The staining steps were as follows: sections were deparaffinized, rehydrated and rinsed in PBS for 5 min. antigen retrieval was carried out in 5-mM citrate buffer. after inactivation of endogenous peroxidase with 5% H 2 o 2 for 30 min at room temperature, the sections were blocked with rabbit serum for 30 min at 37˚C and then incubated with the primary antibodies diluted 1:50-100 overnight at 4˚C. The sections were incubated in biotinylated rabbit anti-mouse IgG for 30 min at 37˚C and developed with 0.05% DAB + 0.03% H 2 o 2 for 5-10 min. running water was used to terminate the reaction. Finally, sections were counterstained with hematoxylin and mounted with neutral resin solution. as a negative control, PBS was used instead of primary antibody. The section known to be positive for Hcc was used as the positive control.
Results

Proteomic pattern of hepatocellular carcinoma and altered
hepatocytes by 2-DE. The 2-de maps of Hcc, liver cirrhosis nodules, altered hepatocytes and mixed liver cell foci were obtained using identical methodology, repeated twice in each case. The results of 2-de revealed that the protein expression pattern in the same case with different histological morphology was quite similar; indeed, it was possible to match the majority of protein spots with each other. However, a number of protein spots were differentially expressed, indicating that certain protein spots only appeared in the Hcc tissues while others were only expressed in the liver cirrhosis altered liver cell nodules. it is also possible that the quality of protein expression differed between cases ( Figs. 1 and 2 ).
MALDI-TOF MS analysis and identification of differential
proteins. a total of 95 differentially expressed protein spots (57 Hcc, 10 liver cirrhosis nodules, 13 large-cell mixed liver cell foci and 15 altered hepatocytes nodules) were identified and cut from the 2-de gels. By Maldi-ToF MS following in-gel digestion with TPCK-trypsin, the peptide mass fingerprinting (PMF) maps of all the spots were obtained. These PMFs were used to search ncBinr and Swiss-Port databases using Mascot or ProFound software. Based on the molecular weight and isoelectric point of the 2-de protein spots, 80 proteins were identified: 48 proteins overexpressed in HCC (Table i) and 32 proteins overexpressed in other liver lesions, excluding Hcc (Table ii) .
Expression of HSP70 and Cathepsin D in primary hepatocellular carcinoma. cath-d and HSP70
, which were highly expressed in HCC tissue, were identified by proteomics techniques. in order to further examine the characteristics of these proteins, we confirmed the expression of Cath-D and HSP70
in Hcc cells by immunohistochemistry with cath-d and HSP70-specific antibody. The results revealed that the HSP70 was expressed at very low levels in normal liver tissue. in the adjacent non-cancerous chronic liver cirrhosis, HSP70 expression was slightly increased in the cytoplasm of some liver cells, and was increased further in altered cell lesions. HSP70 was expressed in almost all the Hcc cancer cells and was located in the cytoplasm, with a brownish yellow staining color and mostly average staining intensity. at the cancer nest edge and in the tissue surrounding the junction, HSP70 was found to be significantly expressed. Cath-D was finely granular in the cytoplasm and membrane of cancer cells. cath-d showed diffuse weak positive expression in large-cell lesions of the liver tissues, whereas in small-cell lesions, the positive cells were located at the edge of lesions. The distribution of positive granules in the cytoplasm was mostly concentrated at the edge of the nucleus away from the sinusoid or the liver cell-adjacent area, or gathered in the center of the liver board (Fig. 3) . in Hcc, cath-d-positive products were mainly located in the membrane of cancer cells or cytoplasma near the membrane as brown granules, and had a significantly increased staining intensity (Fig. 4) .
Discussion
Hcc is one of the most common malignant tumors. due to its late diagnosis and the lack of effective conventional treatments, the mortality rate for Hcc is very high (6, 7) . When diagnosed during the early stages, Hcc has a 5-year survival rate due to the availability of more effective treatments and the better bodily function of the patients. early diagnosis is therefore crucial for the successful treatment of Hcc, and the identification of a highly-sensitive and selective biological marker is essential for early diagnosis. in the past, proteomics analysis of Hcc mostly used liver cancer cell lines or tumor tissue extracts to analyze changes in the protein expression profile (8, 9) . Due to the complexity and heterogeneity of tumor tissue, it is impossible to collect the same types of cell groups; rather a mixture of many cell components is obtained. although tumor cells in vitro are very similar to tumor cells in the complex environment of the body, they demonstrate a variety of features, which differ in some respects. In this study, the specific cells directly obtained from the tissue of pre-cancerous lesions and Hcc by microdissection greatly enhanced the homogeneity of tumor cells. comparative analysis of the protein expression profiles of HCC and precancerous lesions revealed that the differentially expressed proteins were respectively involved in cell growth, differentiation and proliferation, protein synthesis and metabolism, and signal transduction. examination of these proteins may aid in the identification of the protein molecular markers for the early diagnosis of Hcc and contribute to the understanding of the molecular mechanisms of hepatocarcinogenesis.
What follows is a discussion of the function of the differentially expressed proteins identified in the present study, and their relation to the development of Hcc.
Transgelin 2 and Stratifin. Transgelin 2 and Stratifin may be specific diagnostic markers of hepatocellular carcinoma. Transgelin 2 was highly expressed in Hcc, but was not detected in the pre-cancerous lesions. To our knowledge, the overexpression of Transgelin in Hcc has not been previously reported. Transgelin, also known as SM22-α, of the calciumbinding protein family, is an actin-binding protein with a molecular weight of 22 kda. Transgelin was overexpressed in gastric cancer and renal cell carcinoma, and was capable of inducing igG responses in vivo in some patients (10) (11) (12) . in order to identify a potential diagnostic marker for liver cancer and immunotherapy molecular targets, Shi et al (13) detected tumor antigens and tumor-associated antigens in patients with Hcc by serological analysis of cdna expression libraries (SereX). in 30 antigens reacted with serum igG from Hcc patients, the mrna expression patterns of 14 tumor samples were altered, 9 of which were up-regulated and 5 down-regulated. Transgelin 2 mRNA showed high expression in 69% of the liver samples (13) . in the present study, Transgelin 2 protein was detected in Hcc tissues, suggesting that it may be a diagnostic marker of Hcc.
Stratifin (SFN; 14-3-3σ) protein is a member of the 14-3-3 superfamily. SFn can be combined with a variety of proteins, including signal protein kinase, phosphorylase and transmembrane receptors, and plays an important role in the regulation of the cell cycle and cell apoptosis (14) . in recent years, the function of SFN (14-3-3σ) in tumors has been reported, but with varying results in different epithelial tumors. As a major G2/M checkpoint controlling gene, 14-3-3σ is inactive in a variety of cancers, due mostly to hypermethylation (15, 16) . in cervical dysplasia and squamous cell carcinoma, 14-3-3σ showed diffuse strong positive expression, related to immune activity (17) . SFN was expressed in 97% of intestinal metaplasia, 100% of gastric epithelial dysplasia, and only 3% of normal gastric mucosa samples. Positive expression of 14-3-3σ was also observed in 92% of primary gastric cancers, suggesting that it is very useful for the early diagnosis of human gastric cancer and for targeted therapy of gastric pre-cancerous lesions (18). in the present study, high expression of 14-3-3 σ protein was detected in Hcc tissues, but was not found in the corresponding adjacent non-cancerous tissues, further indicating that the overexpression of 14-3-3σ protein may be related to the development of liver cancer (19) .
Mitochondrial manganese superoxide dismutase. The expression of mitochondrial manganese superoxide dismutase (Mn-Sod) is down-regulated in human hepatocellular carcinoma. Mn-Sod expression was lower in human Hcc tissues than in chronic hepatitis and cirrhosis. it can be speculated that a variety of cytokines are secreted by infiltrating inflammatory cells and inflammatory chemokines in the tumor microenvironment, which induces an increase in Mn-Sod expression. Mn-Sod protects cells from oxidative stress and maintains the normal function of cells. When liver cells were transformed into cancer cells, the amount of Mn-Sod in these cells was reduced. This decrease was associated with a decrease in the mature form of the MnSod transcript, in part accompanied by an increase of the processed form of MnSod transcript. Therefore, the level of Mn-Sod mrna transcription or translation processing may determine the level of Mn-Sod expression of human tumor cells (20) . The reduced expression of Mn-Sod in tumor cells may be related to carcinogenesis and the development of Hcc.
Heat shock protein 70 family. The expression of heat shock protein 70 (HSP70) is up-regulated in human hepatocellular carcinoma. The HSP70 family has three members, including heat shock 70 kda protein 9B and its precursors, heat shock 70 kda protein 5 and glucose-regulated protein (GrP78). These were increasingly expressed in human Hcc. The pathogenesis of Hcc is a complex and multistage process, with the majority of cases involving liver cirrhosis caused by chronic HBV and HcV persistent infections (21) . The development of Hcc is associated with chronic liver disease and generally evolves from pre-cancerous lesions and early-stage cancer to a progressed morphology. chuma et al (22) compared the expression profiles of early and progressed HCCs and their corresponding non-cancerous liver tissues with an oligonucleotide array. The results showed that HSP70 was the most up-regulated gene in early Hcc. Further examination using immunohistochemistry and RT-PCR confirmed this finding. The level of expression of HSP70 in progressed Hcc was significantly higher than that in early HCC. The expression of HSP70 in early Hcc was higher than in pre-cancerous lesions (22) . The expression of HSP70 has been found to gradually increase with the development of liver cancer. The immunohistochemical results of the present study support this finding, suggesting that HSP70 may be a sensitive marker in the differential diagnosis of early liver cancer and pre-cancerous lesions compared to non-cancerous liver tissue.
Cathepsin-D. cath-d may play different roles in the process of hepatocarcinogenesis. In the present study, we verified the up-regulation of the proteins HSP70 and cath-d in 28 cases of liver cancer and cirrhosis using immunohistochemistry. The results showed that cath-d is not only expressed in cancer tissue, but also in liver cirrhosis adjacent to cancer, nodules of altered hepatocytes and normal liver tissues. However, the position of cath-d in cells is different in different tissues, suggesting that the function of cath-d may be changed in Hcc carcinogenesis.
Maguchi purified an apparently homogeneous form of cath-d from normal human liver and hepatocellular cancer in 1988, and found that the origin of purified Cath-D could not be distinguished from normal liver or liver cancer in terms of specific activity, antigenicity, subunit and amino acid composition or trypsin peptides (23) . However, the purified enzyme from liver cancer showed greater heterogeneity of the charge, which produced a variety of acidic variants, whereas in the normal liver the enzyme was deficient or present in very low amounts. The amount of cath-d mannose-6-phosphate in liver cancer was twice that of the normal liver. Therefore, the heterogeneity of cath-d in tumor tissue may be related to the carcinogenesis of liver cancer.
This study also detected other protein molecules related to the development of liver cancer, such as prohibitin PHB, dJ-1, α-enolase, PdX6, aldehyde-ketone reductase B10, PGK1 and α1-aT. although their role and function in the development of Hcc is not entirely clear, they are expected to become candidate markers for future study of the mechanisms of liver cancer.
